- HPV vaccination rates among girls stalled in 2012, CDC says
- PhRMA report lists 271 vaccines in development
- Walgreens partners with Chicago Public Schools and city health department on Tdap vaccination project
- Walgreens partners with United Nations Foundation's Shot@Life campaign
- Shoppers Drug Mart report: Allowing pharmacists in Canada to immunize could save lives, money
ATLANTA — An advisory committee of the Centers for Disease Control and Prevention is recommending that all boys ages 11 and 12 years old get vaccinated against human papillomavirus, the CDC said Tuesday.
The agency said the Advisory Committee on Immunization Practices voted for recommending routine vaccination of boys with three doses of HPV4 to protect against the virus. The vaccination is able to prevent such HPV-related conditions as cancer and prevent the spread of the virus to sexual partners. The recommendation is still subject to the CDC's approval, the agency said.
The CDC already recommends the routine vaccination of girls and women ages 9 to 26 years against the virus.
Two HPV vaccines currently exist on the market: Merck's Gardasil and GlaxoSmithKline's Cervarix.